Navigation Links
Cepheid to Webcast Upcoming Financial Presentations
Date:8/9/2012

SUNNYVALE, Calif., Aug. 9, 2012 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast.

Wedbush PacGrow Life Sciences Conference, New York, NY
Wednesday, August 15, 2012 at 10.20 a.m. Eastern Time

Baird Health Care Conference, New York, NY
Thursday, September 6, 2012 at 12.10 p.m. Eastern Time

Morgan Stanley Global Healthcare Conference, New York, NY
Wednesday, September 12, 2012 at 9.45 a.m. Eastern Time

UBS Global Life Sciences Conference, New York, NY
Thursday, September 20, 2012 at 9.30 a.m. Eastern Time

Credit Suisse Small & Mid Cap Conference, New York, NY
Friday, September 21, 2012 at 8.00 a.m. Eastern Time

Additionally, Cepheid announced that it will host an Analyst Event featuring management presentations and a question and answer session in New York, NY on Thursday, September 27, 2012 starting at 8.00 a.m. Eastern Time.  Attendance at the event is by invitation only, although Cepheid welcomes all interested parties to access the proceedings via a live audio webcast as detailed below.

Accessing Live Webcasts To access the live webcasts for these events, please visit Cepheid's website at http://ir.cepheid.com at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software.  A replay of the webcasts will be available shortly following the presentation and will remain available for at least 90 days.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to access the full power of molecular diagnostics. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit www.cepheid.com.CONTACTS: For Media Inquiries: For Investor Inquiries:Jared Tipton

Jacquie Ross Cepheid Corporate Communications

Cepheid Investor RelationsTel: (408) 400-8377

Tel: (408) 400-8329communications@cepheid.com 

investor.relations@cepheid.com


'/>"/>
SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
2. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
3. Pro-Dex, Inc. Announces Update Conference Call and Webcast
4. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
5. Cempra, Inc. to Report Second Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on August 8, 2012
6. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. diaDexus, Inc. to Host Webcast August 7, 2012 on Second Quarter 2012 Financial Results
9. HeartWare Schedules Second Quarter Conference Call And Webcast
10. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2012 Financial Results On August 2, 2012
11. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ORANGE COUNTY, Calif. , April 29, 2016 ... technology industry is projected to shift from systems ... can replace all types of modality CRT Medical ... set-up." Although there are a host of foreseeable ... a serious concern; will existing modalities have to ...
(Date:4/29/2016)... April 29, 2016 ReportsnReports.com ... 2016" market research report that provides an overview ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:4/29/2016)... April 29, 2016 Acquisition ... Sciences, Product Development Capabilities in North ... Base . Indegene ( http://www.indegene.com ... the acquisition of Skura Corporation,s life science business. ... adaptive sales enablement technology for life science organizations ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Bernie Siegel, ... seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death live on ... . Dr. Bernie Siegel, author of a plethora of essential books-to-read for ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart ... at its new location in the Exchange Furniture Mall at 112 Vilseck Road in ... 50-inch Samsung Smart TV. Plus attendees will have the opportunity to meet general dentists ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... announced that student team BioCellection won the $30,000 Perlman Grand Prize of the 2016 ... the Gloeckner Undergraduate Award, the Michelson People‚Äôs Choice Award, and the Committee Award ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... the Canadian Celiac Association (CCA), is pleased to announce the launch of the ... products, nutritional articles, recipes, and more. The purpose of the GFCP Scoop ...
(Date:4/29/2016)... , ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon ... is a very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to ... is a procedure that involves one or both jaw bones. This surgery is performed to ...
Breaking Medicine News(10 mins):